Call Us

(949) 763-3440

Text Us

(949) 763-3440

Covered?

Verify Now

Contact

Send Us a Message

MAKER OF MARLBORO CIGARETTES PREPARES TO INVEST $2.4 BILLION IN CANADIAN MARIJUANA COMPANY

Mark Shandrow is Asana Recovery’s CEO and has 20+ years of experience in business development and operations in the addiction treatment industry.
LinkedIn | More info about Mark

Share on:

Share on:

Content

With a market as bizarre and (in a very strange twist) promising as the one for marijuana, you can imagine that some big players have set their sights on the little green plant. From applications to the medical industry to its use in cosmetics and hair care, this fragrant herb has somehow managed to integrate itself into even the strictest of cultures. Recently, though, one of the strangest pairings took place when Altria Group (the creators of the Marlboro cigarette brand) developed an interest in the Cronos Group, a marijuana company based in Canada. Now, the move is official. As of today, Altria is preparing to drop $2.4 billion to invest in Cronos, which leads us to wonder: “What would a cigarette company want with this drug?” Let’s take a closer look at this situation and find out more.

Forming an Ideal Partnership

As part of the initial investment, Altria Group will be granted a 45% ownership stake in the Cronos Group, which will ultimately allow the tobacco giant to provide an additional investment of $1.4 billion to boost the ownership stake to 55%. According to Mike Gorenstein (Chairman, President, and CEO of the Cronos Group), Altria will serve as an ideal partner that will provide invaluable resources and expertise to help Cronos expand into a larger, better developed company. Ultimately, through Altria, Cronos will also have opportunities to expand its global position and distribution capability.

What Else Is in Store?

Based on a recent news release, Altria’s position as a partial owner and solid investor will help Cronos provide resources for marijuana innovation, create high-quality and unique products for medical and recreational use, and expand global/distribution footprints and production capabilities.

As part of this massive deal, Altria will provide numerous years of experience navigating through a sea of complex, tangled government regulations. With their help, Cronos can easily deal with drug regulations, government policies, and compliance and can develop a stronger brand, overall. Likewise, through its partnership, the Canadian pot company wants to look into new technology like vape pens and related products.

Always remember that mind-altering drugs do not have control over your life. You do. Are you suffering from a substance use disorder or a severe form of addiction? Do you have a friend or family member suffering from one or more of these debilitating illnesses? If you do, get in touch with Asana Recovery today. Our counselors and healthcare experts are ready to walk you through every step of the detox and withdrawal process and rehabilitation and guide you towards living a happier, healthier, and freer lifestyle. While the road to recovery might not be an easy road to travel, we promise to help you every step of the way. Take the first step to stay fit, healthy, and safe.

The time for you to take back control of your life is now. If you are interested in one of our residential treatment or supervised detoxification/withdrawal programs, we are ready and waiting to speak with you at your disclosure. Call Asana now at (949) 438-4504 to learn how to overcome your drug abuse or addiction troubles today.

Mark Shandrow is Asana Recovery’s CEO and has 20+ years of experience in business development and operations in the addiction treatment industry.
LinkedIn | More info about Mark

Share on:

We're Here to Help

Take the first step toward a better future—call us today!